Edition:
United Kingdom

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

28.60CAD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$28.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,953,798
52-wk High
$30.56
52-wk Low
$11.20

Chart for

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $5,024.01
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Valeant Pays Down $300 Million Of Senior Secured Term Loans

Jan 3 Valeant Pharmaceuticals International Inc :

03 Jan 2018

Pershing Square, Valeant to appear in court on insider trading suit settlement

A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

03 Jan 2018

Pershing Square, Valeant to appear in court on insider trading suit settlement

A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

03 Jan 2018

UPDATE 1-Pershing Square, Valeant to appear in court on insider trading suit settlement

Jan 2 A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

03 Jan 2018

Pershing Square, Valeant asked to appear for hearing on insider trading suit

Jan 2 A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

03 Jan 2018

BRIEF-Pershing Square Holdings Announces Agreement To Settle Lawsuits Related To Allergan

* PERSHING SQUARE WILL PAY $193.75 MILLION AND VALEANT WILL PAY $96.25 MILLION

02 Jan 2018

Deals of the day-Mergers and acquisitions

Dec 29 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:

29 Dec 2017

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit

Activist investor William Ackman's Pershing Square and Valeant Pharmaceuticals on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc in 2014.

29 Dec 2017

Earnings vs. Estimates